The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 21, 2018
Filed:
Oct. 09, 2013
Applicant:
Temple University of the Commonwealth System of Higher Education, Philadelphia, PA (US);
Inventors:
Oscar M. Perez-Leal, Philadelphia, PA (US);
Salim Merali, Bryn Mawr, PA (US);
Carlos A. Barrero, Philadelphia, PA (US);
Assignee:
TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Philadelphia, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); C12Q 1/68 (2018.01); C12Q 1/6883 (2018.01); A61K 31/05 (2006.01); A61K 31/136 (2006.01); A61K 31/225 (2006.01); A61K 31/353 (2006.01); C07K 14/47 (2006.01); C12Q 1/6897 (2018.01);
U.S. Cl.
CPC ...
G01N 33/5023 (2013.01); A61K 31/05 (2013.01); A61K 31/136 (2013.01); A61K 31/225 (2013.01); A61K 31/353 (2013.01); C07K 14/4701 (2013.01); C12Q 1/6883 (2013.01); C12Q 1/6897 (2013.01); C12Q 2600/156 (2013.01);
Abstract
Compositions include nucleic acid sequences encoding the C-terminal fragment of fragment (Seg3) of Nuclear factor-erythroid 2 related factor 2 (Nrf2). These compositions provide a target for identification of novel therapeutics having the ability to modulate the translation of Nrf2. Methods of treating subjects are also provided.